RhumbLine Advisers’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.75M Buy
169,275
+4,925
+3% +$251K 0.01% 1122
2025
Q4
$8.17M Sell
164,350
-5,452
-3% -$265K 0.01% 1157
2025
Q3
$8.11M Sell
169,802
-2,428
-1% -$97.8K 0.01% 1182
2025
Q2
$5.43M Buy
172,230
+6,907
+4% +$221K ﹤0.01% 1366
2025
Q1
$5.41M Sell
165,323
-7,121
-4% -$252K 0.01% 1319
2024
Q4
$6.24M Buy
172,444
+800
+0.5% +$28.2K 0.01% 1318
2024
Q3
$5.35M Sell
171,644
-8,630
-5% -$269K ﹤0.01% 1392
2024
Q2
$4.82M Buy
180,274
+5,813
+3% +$168K ﹤0.01% 1423
2024
Q1
$5.95M Sell
174,461
-3,260
-2% -$97.1K 0.01% 1320
2023
Q4
$5.14M Buy
177,721
+11,177
+7% +$296K 0.01% 1395
2023
Q3
$4.59M Buy
166,544
+1,966
+1% +$59.8K 0.01% 1405
2023
Q2
$4.95M Sell
164,578
-9,388
-5% -$329K 0.01% 1377
2023
Q1
$6.3M Buy
173,966
+9,015
+5% +$347K 0.01% 1189
2022
Q4
$5.88M Buy
164,951
+3,647
+2% +$127K 0.01% 1195
2022
Q3
$5.46M Buy
161,304
+7,042
+5% +$229K 0.01% 1175
2022
Q2
$4.46M Buy
154,262
+5,932
+4% +$170K 0.01% 1302
2022
Q1
$4.79M Buy
148,330
+3,477
+2% +$107K 0.01% 1341
2021
Q4
$4.22M Sell
144,853
-2,105
-1% -$63.9K 0.01% 1456
2021
Q3
$3.92M Sell
146,958
-18,246
-11% -$490K 0.01% 1499
2021
Q2
$5.09M Sell
165,204
-1,519
-0.9% -$46.6K 0.01% 1417
2021
Q1
$4.37M Buy
166,723
+4,521
+3% +$126K 0.01% 1477
2020
Q4
$4.08M Buy
162,202
+9,104
+6% +$196K 0.01% 1474
2020
Q3
$3.19M Sell
153,098
-19,372
-11% -$440K 0.01% 1427
2020
Q2
$4.1M Buy
172,470
+4,534
+3% +$100K 0.01% 1324
2020
Q1
$3.02M Buy
167,936
+2,898
+2% +$60.9K 0.01% 1324
2019
Q4
$3.92M Buy
165,038
+10,716
+7% +$260K 0.01% 1403
2019
Q3
$4.24M Buy
154,322
+3,280
+2% +$97.2K 0.01% 1278
2019
Q2
$5M Buy
151,042
+6,079
+4% +$208K 0.01% 1202
2019
Q1
$5.08M Buy
144,963
+616
+0.4% +$22.9K 0.01% 1169
2018
Q4
$4.79M Buy
144,347
+25,153
+21% +$1.08M 0.01% 1133
2018
Q3
$6M Sell
119,194
-2,472
-2% -$122K 0.01% 990
2018
Q2
$7.28M Buy
121,666
+4,248
+4% +$220K 0.01% 849
2018
Q1
$5.38M Buy
117,418
+4,031
+4% +$168K 0.01% 993
2017
Q4
$4.52M Buy
113,387
+16,630
+17% +$657K 0.01% 1128
2017
Q3
$3.87M Buy
96,757
+2,850
+3% +$123K 0.01% 1200
2017
Q2
$4.05M Buy
93,907
+288
+0.3% +$10.3K 0.01% 1128
2017
Q1
$2.93M Buy
93,619
+28,420
+44% +$762K 0.01% 1332
2016
Q4
$1.65M Buy
65,199
+4,151
+7% +$92.8K ﹤0.01% 1564
2016
Q3
$1.51M Buy
61,048
+9,665
+19% +$219K ﹤0.01% 1583
2016
Q2
$1.05M Buy
51,383
+11,485
+29% +$204K ﹤0.01% 1756
2016
Q1
$608K Buy
39,898
+280
+0.7% +$3.65K ﹤0.01% 2088
2015
Q4
$532K Buy
39,618
+4,000
+11% +$61.9K ﹤0.01% 2203
2015
Q3
$500K Buy
35,618
+2,236
+7% +$41.6K ﹤0.01% 2223
2015
Q2
$567K Buy
33,382
+6,040
+22% +$86K ﹤0.01% 2246
2015
Q1
$331K Buy
27,342
+4,800
+21% +$45.4K ﹤0.01% 2552
2014
Q4
$187K Buy
22,542
+700
+3% +$5.88K ﹤0.01% 2842
2014
Q3
$190K Hold
21,842
﹤0.01% 2784
2014
Q2
$239K Buy
21,842
+9,540
+78% +$85K ﹤0.01% 2725
2014
Q1
$110K Sell
12,302
-560
-4% -$5.16K ﹤0.01% 2910
2013
Q4
$97K Hold
12,862
﹤0.01% 2957
2013
Q3
$94K Sell
12,862
-134
-1% -$900 ﹤0.01% 2938
2013
Q2
$84K Buy
+12,996
New +$76.5K ﹤0.01% 3268

Other funds holding SUPN